Estradiol Hemihydrate

5 trials 3 recruiting GUrology & Gynaecology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

3 Recruiting

1 Completed trials

5 Sponsors

4 Countries

Phase III

Phase II

Phase IV

Phase III: 3 Phase II: 1 Phase IV: 1

Indications tested

Hormone receptor positive HER2 negative breast cancer 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 1 BOOG Study Center B.V. 1 Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer 1 Region Hovedstaden 1 Santiago Dexeus Font Fundacio Privada 1

All trials

5 total

COMPASS - COpenhagen MenoPAuSe Study Pending

2025-522558-37-00 Phase II 1 country Region Hovedstaden
Prospective randomized study on sexual health and self-perceived quality of life (PROMs) in patients treated for cervical cancer Recruiting

2025-521460-36-00 Phase IV 1 country Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques Augus…
Evaluation of the effectiveness of hormonal treatment in adolescents suffering from gender dysphoria Recruiting

2024-513250-30-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of two formulations of vaginal micronized progestero… Recruiting

2024-513102-57-00 Phase III 1 country Santiago Dexeus Font Fundacio Privada
Endocrine therapy plus CDK 4/6 inhibition in first- or second-line for hormone receptor positive advanced breast cancer - the SONIA study Ended

2024-516204-42-00 Phase III 1 country BOOG Study Center B.V.

Showing 1–5 of 5 trials

← All drugs A–Z